查找临床试验
已按「类风湿关节炎」检索，对应国际通用词 rheumatoid arthritis
共找到 67 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 22:14，每 5 分钟自动同步A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
China
年龄 18 Years – 65 Years
China Immunotech (Beijing) Biotechnology Co., Ltd.
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
China
年龄 18 Years – 65 Years
Peking University People's Hospital
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
United States、Canada、Czechia、Germany、Hungary 等 12 国
年龄 18 Years – 不限
AbbVie
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
United States、Australia、Canada、China、Colombia 等 6 国
年龄 18 Years – 100 Years
Novartis Pharmaceuticals
Safety Study of CC312 in Autoimmune Disease Patients
China
年龄 18 Years – 不限
CytoCares Inc
Research on the Application of 99mTc-TCR-FAPI SPECT Imaging in Rheumatoid Arthritis
China
年龄 18 Years – 75 Years
Luo Yaping
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
China
年龄 18 Years – 不限
Peking University People's Hospital
Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease
China
年龄 18 Years – 70 Years
Peking University People's Hospital
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
China
年龄 18 Years – 80 Years
Peking University Third Hospital
The Clinical Efficacy of Immunomodulators in RA Patients
China
年龄 18 Years – 80 Years
Qilu Hospital of Shandong University
Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis
China
年龄 18 Years – 65 Years
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
China
年龄 18 Years – 85 Years
Zhejiang Provincial People's Hospital